Genentech to Pay $20M in Rituxan Whistleblower Lawsuit– 12/02/11

Genentech, the San Francisco-based U.S. subsidiary of Swiss pharmaceutical giant Roche, will pay $20 million to settle a whistleblower lawsuit brought in 2003. The suit claims that from 2000 to at least 2002, Genentech “encouraged oncologists and other physicians and medical providers to bill Medicare and other government reimbursement programs for Rituxan for off-label uses.” The suit also states that the company paid kickbacks to doctors and put pressure on sales reps to increase off-label uses.

Read more at: